Position in ABCL
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$10,469,776
+$1,465,355 QoQ
Shares Held
2,999,936
+13.9% QoQ
Ownership
0.982%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 138 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Derivatives in ABCL
reported options exposure · as of Jun 30, 2021CallValue
$0
CallShares
0
PutValue
$1,850,200
PutShares
84,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $8,554,846,017 across 346 Biotechnology names. ABCL ranks #103 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,878,183 | $1,285,223,834 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,189,584 | $919,120,177 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
966,912 | $319,922,169 | |
| 4 | ARGX |
Argenx SE
|
400,117 | $292,185,437 | |
| 5 | INSM |
INSMED Inc
|
1,502,281 | $245,652,986 | |
| 6 | CYTK |
Cytokinetics Inc
|
3,125,436 | $205,997,485 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,014,800 | $191,847,936 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,913,109 | $188,274,232 |
All Filings in ABCL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,469,776 | 2,999,936 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $9,004,421 | 2,632,872 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $12,164,068 | 2,418,304 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $769,571 | 224,365 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $35,622 | 15,975 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $50,221 | 17,141 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $49,599 | 19,077 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $30,310 | 10,240 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $711,585 | 157,083 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $979,355 | 171,516 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $812,056 | 176,534 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $276,248 | 42,763 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,246,821 | 165,361 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $986,955 | 97,429 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $755,219 | 76,362 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $472,625 | 44,378 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $113,529 | 11,644 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $58,744 | 4,108 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $49,037 | 2,447 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,907,752 | 86,716 | Shares | Defined | 2021-09-13 | |
| 2021-06-30 | $1,850,200 | 84,100 | Put | Defined | 2021-09-13 | |
| 2021-03-31 | $33 | 1 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||